Vericel to Present at the 5th Annual Cell & Gene Therapy Investor Day – GlobeNewswire (press release)
|
Vericel to Present at the 5th Annual Cell & Gene Therapy Investor Day
GlobeNewswire (press release) CAMBRIDGE, Mass., April 20, 2017 (GLOBE NEWSWIRE) — Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that Nick … |
